Related by context. All words. (Click for frequent words.) 77 Plicera 71 Dacogen injection 71 registrational trial 71 migalastat HCl 70 PRT# 70 HuMax CD4 69 Cetrorelix 69 otelixizumab 69 Phenoptin 69 INCB# [001] 69 velaglucerase alfa 69 JAK inhibitor 69 Zerenex 69 obatoclax 69 pralatrexate 69 HuLuc# 68 forodesine 68 eniluracil 68 ocrelizumab 68 HGS ETR1 68 ganetespib 68 Panzem R NCD 68 custirsen 68 valopicitabine 68 elotuzumab 68 Virulizin ® 68 GALNS 68 Icatibant 68 HCD# [002] 68 CEQ# 68 HuMax EGFr 68 tivozanib 67 tanespimycin 67 methylnaltrexone 67 Alzhemed TM 67 Amrubicin 67 atacicept 67 sapacitabine 67 IMA# 67 JAK inhibitors 67 aflibercept 67 Archexin 67 pharmacological chaperone 67 ponatinib 67 YONDELIS 67 MGCD# [001] 67 Genz # 67 TYZEKA 67 VPRIV 67 BENLYSTA ® 67 TREANDA 67 Ceflatonin 67 oral prodrug 67 HspE7 67 Xanafide 67 alvespimycin 67 AEG# 67 Fodosine 66 Sym# 66 RG# [001] 66 ASONEP 66 OncoVEX GM CSF 66 BAY #-# 66 Talabostat 66 celgosivir 66 vemurafenib 66 EOquin 66 PROMACTA 66 UPLYSO 66 registrational 66 docetaxel Taxotere R 66 CA4P 66 TACI Ig 66 MAXY G# 66 panitumumab 66 selective modulator 66 ATL# [001] 66 Chemophase 66 L BLP# 66 decitabine 66 Bicifadine 66 TBC# 66 BEXXAR 66 daclizumab 66 blinatumomab 66 Diamyd ® 66 liposomal formulation 66 epothilone 66 Phase IIb trials 66 Troxatyl 66 HGS ETR2 66 Allovectin 7 66 ADVEXIN 66 dimebon 66 lumiliximab 66 Traficet EN 66 sodium glucose cotransporter 66 Asentar 66 Phase 2b trial 65 tyrosine kinase inhibitor 65 omacetaxine 65 torezolid phosphate 65 docetaxel Taxotere ® 65 ofatumumab 65 posaconazole 65 Amigal TM 65 faropenem 65 belinostat 65 phase IIb clinical 65 TELINTRA 65 uric acid lowering 65 TOCOSOL Paclitaxel 65 fostamatinib 65 Personalized Immunotherapy 65 Phase Ib 65 enzastaurin 65 GAMMAGARD 65 Proxinium TM 65 Pralatrexate 65 Symadex 65 PXD# 65 orally bioavailable 65 Phase 2a trial 65 glufosfamide 65 Fx #A 65 pegylated interferons 65 perifosine 65 HQK 65 Fludara 65 CoFactor 65 NEBIDO 65 Clolar ® 65 sunitinib 65 CIMZIA TM 65 confirmatory Phase III 65 Blinatumomab 65 Restanza 65 sunitinib malate 65 SPRYCEL ® 65 MEK inhibitor 65 Tasimelteon 65 Torisel 65 personalized immunotherapy 65 Viramidine 65 Bezielle 65 Civacir 65 ELND# 65 INCB# [002] 65 albinterferon alfa 2b 65 antibody MAb 65 PS# [001] 65 fidaxomicin 65 phase IIb trial 65 Phase IIb clinical trials 65 Dasatinib 65 INT# [002] 65 Campath ® 65 FOLOTYN 65 IRX 2 65 Genasense 65 MyVax R 65 BLA filing 64 orBec 64 ISTODAX 64 phase IIa clinical 64 prGCD 64 Allovectin 7 R 64 OHR/AVR# 64 Romiplostim 64 Phase #b/#a 64 romiplostim 64 MYDICAR ® 64 dacetuzumab 64 tezampanel 64 TRIOLEX 64 pertuzumab 64 biologic therapy 64 targeted radiotherapeutic 64 ataluren 64 Phase IIa trials 64 dasatinib Sprycel 64 voreloxin 64 PF # [001] 64 dexpramipexole 64 PDE4 inhibitor 64 adult chronic ITP 64 taliglucerase alfa 64 Surfaxin LS 64 PEG Interferon lambda 64 Irinotecan 64 Mipomersen 64 picoplatin 64 Azedra 64 Panzem R 64 JAK1 64 Allovectin 7 ® 64 GLP toxicology studies 64 Phase IIb trial 64 receptor tyrosine kinase inhibitor 64 Phase Ib study 64 Factor VIIa 64 MAGE A3 ASCI 64 vandetanib 64 Campath alemtuzumab 64 oritavancin 64 Altastaph 64 MAA submission 64 oral ridaforolimus 64 Insegia 64 romidepsin 64 LymphoStat B 64 FOLOTYN ® 64 ixabepilone 64 amrubicin 64 Laquinimod 64 bardoxolone 64 TRO# 64 Aflibercept 64 elesclomol 64 proteasome inhibitor 64 bendamustine 64 alvimopan 64 HuMax CD# 64 Ceflatonin R 64 Vilazodone 64 Desmoteplase 64 Actilon 64 denufosol 64 lesinurad 64 PLK1 SNALP 64 XmAb# 64 Vidaza azacitidine 64 lomitapide 64 Omacetaxine 64 PrevOnco ™ 64 IMC A# 64 visilizumab 64 Cethromycin 64 BCR ABL inhibitor 64 urocortin 2 64 Ofatumumab 64 subcutaneous formulation 64 HCV protease inhibitor 64 mipomersen 64 Arranon 64 rNAPc2 64 Hematide 64 cilengitide 64 Pimavanserin 64 pradefovir 64 bortezomib Velcade 64 DAVANAT R 64 somatostatin analogue 64 RDEA# 64 cutaneous T 64 AP# [003] 64 Vandetanib 64 OXi# 64 Plenaxis TM 64 TORISEL 64 BAL# [002] 64 PEG PAL 64 EOquin TM 64 Glufosfamide 64 alpha 2a 64 Dalbavancin 64 Menerba 64 vidofludimus 64 Ophena TM 64 ridaforolimus 63 Evoltra ® 63 ALN TTR# 63 cell lymphoma CTCL 63 Cellegesic 63 investigational therapies 63 BRIM2 63 Aviptadil 63 R#/MEM # 63 Phase 2b study 63 EndoTAG TM -1 63 pomalidomide 63 volociximab 63 Sebivo 63 pegfilgrastim 63 Soliris TM eculizumab 63 Phase 1b 63 HGS# 63 phase IIb 63 multi kinase inhibitor 63 rHuPH# 63 lintuzumab 63 LEUKINE 63 Ocrelizumab 63 rindopepimut 63 rilonacept 63 Gleevec resistant 63 teriflunomide 63 LymphoStat B belimumab 63 octreotide 63 Inhalation Solution 63 brivaracetam 63 Nuvion 63 OvaRex ® MAb 63 ATryn R 63 SinuNase TM 63 Nexavar ® 63 Capesaris 63 SUTENT 63 Fabry Disease 63 R sorafenib tablets 63 ISIS # 63 IRESSA 63 KNS # 63 NXL# 63 Phase Ib II 63 CDP# 63 eprotirome 63 pafuramidine 63 Granulocyte Colony Stimulating Factor 63 GED aPC 63 Promacta 63 UVIDEM 63 Increlex R 63 dasatinib Sprycel ® 63 Fibrillex TM 63 luliconazole 63 Cannabinor 63 Zalbin 63 Alemtuzumab 63 Corlux 63 Firazyr 63 synthetic retinoid 63 Aplidin 63 angiogenesis inhibitor 63 placebo controlled Phase 63 CCX# 63 IL# PE#QQR 63 adecatumumab 63 Hycamtin 63 Phase 1b trial 63 generation purine nucleoside 63 ACTEMRA 63 Panzem 63 SNT MC# 63 G#DT 63 MEK inhibitors 63 chemotherapy induced neutropenia 63 riociguat 63 lupus nephritis 63 cannabinor 63 GFT# 63 Interferon alpha 63 Androxal ® 63 subcutaneously administered 63 Onalta 63 MNTX 63 OMAPRO 63 Aptivus ® 63 Bortezomib 63 DAVANAT 63 midstage trials 63 Phase 2a clinical trials 63 ELACYT 63 selective androgen receptor modulator 63 ruxolitinib 63 BiTE antibody 63 Valortim 63 Protexia R 63 Annamycin 63 BLA submission 63 peginterferon 63 liprotamase 63 vosaroxin 63 MGd 63 GlycoPEG GCSF 63 AVASTIN 63 VAPRISOL 63 RIGScan CR 63 viral kinetics 63 AZILECT R 63 pan HDAC inhibitor 63 Clevudine 63 Urocidin 63 rFIXFc 63 teduglutide 63 AZX# 63 chronic HCV infection 63 REPLAGAL 63 OPAXIO 63 Pivotal Phase 63 Benlysta belimumab 63 pitavastatin 63 Sapacitabine 63 metaglidasen 63 Ixempra 63 ADP receptor antagonist 63 TOLAMBA 63 6R BH4 63 Tamibarotene 63 ganaxolone 63 Azixa 63 atrasentan 63 Intravenous CP 63 interferon gamma 1b 63 PHX# 63 epothilones 63 Egrifta 63 Noxafil 63 AZILECT ® 63 gefitinib Iressa 63 anticancer compound 63 HCV SPRINT 63 ulimorelin 63 investigational humanized monoclonal antibody 63 MOZOBIL 63 Virulizin R 63 MabCampath 63 ONTAK 63 SAR# [004] 63 Entereg R 63 PEG interferon 63 Technosphere Insulin 63 PrevOnco 63 INTELENCE 63 NOXAFIL 63 depsipeptide 63 Soliris eculizumab 63 clofarabine 63 Lixivaptan 63 Stimuvax R 63 LY# [003] 63 axitinib 63 IMC #B 63 alkylating agent 63 CR# vcMMAE 63 AzaSite Plus 63 eltrombopag 63 Taxotere ® 63 AAG geldanamycin analog 63 deforolimus 63 Tyrima 63 Tavocept 63 PDX pralatrexate 63 Increlex ® 63 pegylated interferon alpha 63 PNP inhibitor 63 DU #b 63 LymphoStat B TM 63 phase Ib 63 CYT# potent vascular disrupting 63 maribavir 63 dirucotide 63 Aurora kinase 63 SUTENT ® 63 HoFH 63 Sudhir Agrawal D.Phil 63 eculizumab 63 refractory gout 63 RGB # 63 relapsed multiple myeloma 63 XYOTAX TM 63 Junovan 63 Nasulin 63 Panitumumab 63 myelodysplastic syndromes MDS 63 anti EGFR antibody 63 PD LID 63 MAXY alpha 63 pain palliation 63 Shigamabs ® 63 Elagolix 63 dirucotide MBP# 63 epigenetic therapies 63 Telaprevir 62 EDEMA3 62 CTAP# Capsules 62 Xcytrin R 62 sorafenib tablets 62 castrate resistant prostate cancer 62 RSD# 62 Seliciclib 62 acyclovir Lauriad R 62 RITUXAN 62 Evoltra 62 micafungin 62 MKC# MT 62 Serdaxin 62 Nexavar sorafenib 62 farletuzumab 62 Aurexis 62 canakinumab 62 XL# XL# 62 Quinamed 62 dasatinib 62 Phase IIa clinical trials 62 bosutinib 62 refractory chronic lymphocytic 62 panitumumab Vectibix 62 Catena ® 62 Synavive 62 NEUPOGEN 62 Neulasta ® 62 terlipressin 62 erlotinib Tarceva ® 62 Ozarelix 62 TMC# [002] 62 MyVax 62 telbivudine 62 investigational monoclonal antibody 62 reslizumab 62 mertansine 62 midstage studies 62 CBLC# 62 palifosfamide 62 ALN PCS 62 Pivotal Phase III 62 TELCYTA 62 SUCCEED trial 62 XL# [003] 62 ceftaroline 62 elvucitabine 62 Hedgehog antagonist 62 #D#C# 62 PRTX 62 Shigamabs R 62 DXL# 62 tolevamer 62 NGX# 62 YONDELIS R 62 RezularTM 62 teplizumab 62 Bronchitol 62 baminercept 62 ALN RSV# 62 LHRH antagonists 62 tasimelteon 62 Pivotal Trial 62 nalbuphine ER 62 evaluating tivozanib 62 Guanilib 62 Hematide ™ 62 lintuzumab SGN 62 Daclizumab 62 ALN VSP 62 regorafenib 62 peginesatide 62 trabectedin 62 Diamyd R 62 CCR5 antagonist 62 Rebif ® 62 Dapagliflozin 62 rhThrombin 62 INTEGRILIN 62 Excellarate 62 orally administered inhibitor 62 novel VDA molecule 62 cetuximab Erbitux 62 GPIIb IIIa 62 midstage clinical 62 darapladib 62 Phase #/#a 62 CCR5 mAb 62 DEB# 62 MBP# [001] 62 PROVENGE sipuleucel T 62 veltuzumab 62 PEG SN# 62 IAP inhibitor 62 zalutumumab 62 taxane 62 chronic ITP patients 62 Genasense ® 62 virus HCV protease inhibitor 62 LibiGel ® 62 Copegus ribavirin 62 docetaxel chemotherapy 62 Tekamlo 62 hereditary deficiency 62 Perifosine 62 Kuvan 62 APTIVUS 62 Yervoy 62 DPP4 62 APTIVUS r 62 Enzyme Replacement Therapy 62 oral taxane 62 daptomycin 62 Marqibo 62 trastuzumab DM1 T DM1 62 ATryn ® 62 Folotyn 62 CTA# Injection 62 Tarceva TM 62 ALN TTR 62 Pafuramidine 62 Prestara 62 FTY# 62 TG# [003] 62 Behcet uveitis 62 sargramostim 62 Evoltra TM 62 rFVIIIFc 62 EFAPROXYN 62 VEGF inhibitor 62 Myocet 62 pivotal Phase III 62 bevacizumab Avastin ® 62 OZURDEX ® 62 Revimmune 62 IAP inhibitors 62 IDX# 62 Leukine ® 62 Phase III clinical 62 mRCC 62 Aryplase 62 PSN# [002] 62 EGFR inhibitors 62 HuMax TAC 62 Leukine 62 non nucleoside 62 Uvidem 62 CANCIDAS 62 ritonavir boosted danoprevir 62 favorable pharmacokinetic profile 62 ACTEMRA TM 62 CD# CEA 62 Theratope 62 GAMMAGARD LIQUID 62 PANVAC VF 62 VIDAZA 62 gemcitabine Gemzar ® 62 evaluating picoplatin 62 Phase III Clinical Trial 62 therapeutic monoclonal antibody 62 MyVax ® 62 pegloticase 62 tremelimumab 62 tecarfarin 62 Azilect ® 62 Albuferon 62 Temsirolimus 62 NTDDS 62 Exelixis XL# 62 Jevtana 62 Preclinical studies suggest 62 L MTP PE 62 Cinryze ™ 62 azacitidine 62 Phase IIb clinical 62 DR Cysteamine 62 PKC# 62 SEBIVO 62 HepaGam B 62 Genasense ® oblimersen 62 ozarelix 62 CCR5 inhibitors 62 PROCHYMAL 62 Ostarine 62 IIa trial 62 Fludara ® 62 imatinib Gleevec 62 Elvitegravir 62 luteinizing hormone releasing 62 bevirimat 62 rALLy clinical trial 61 Omapro 61 TLR9 agonist 61 entinostat 61 NVA# 61 cMET 61 histone deacetylase HDAC inhibitor 61 mTOR kinase 61 Clofarabine 61 xanthine oxidase inhibitor 61 NS5A 61 talabostat 61 ularitide 61 mifamurtide 61 HyQ 61 EGS# 61 XL# XL# XL# XL# 61 hormone LHRH antagonist 61 AVN# [001] 61 pharmacokinetic PK study 61 lymphoma CTCL 61 Cloretazine ® 61 pediatric acute lymphoblastic 61 histamine dihydrochloride 61 HepeX B 61 GRNVAC1 61 T#I [002] 61 Velcade bortezomib 61 abatacept 61 abiraterone acetate 61 MEPACT 61 galiximab 61 NEUMUNE 61 eliglustat tartrate 61 Arcalyst 61 CRMD# 61 humanized anti 61 NS4A 61 ribavirin RBV 61 NUVIGIL 61 preclinically 61 Xcellerated T Cells 61 aleglitazar 61 RLY# 61 nucleoside analog 61 cutaneous T cell 61 drug ISA# 61 Actemra 61 Cancidas 61 registrational studies 61 relapsed ovarian cancer 61 PROVENGE ® 61 XL# anticancer compounds 61 CIMZIA ™ 61 StaphVAX 61 DORIBAX 61 multiple myeloma MM 61 erlotinib Tarceva 61 velafermin 61 Clolar 61 ASA# 61 calcineurin inhibitors 61 Elotuzumab 61 Cloretazine 61 anticancer therapies 61 vismodegib 61 oral methylnaltrexone 61 BENLYSTA 61 samalizumab 61 ENMD # 61 LEP ETU 61 Phase 2b clinical 61 VEGF Trap 61 NPSP# 61 low dose cytarabine 61 Trizytek 61 multicenter Phase II 61 BCR ABL inhibitors 61 Phase #b/#a trial 61 cathepsin K inhibitor 61 JAK3 61 investigational compound 61 tramiprosate 61 EVIZON 61 oral antiviral 61 Nebido 61 talactoferrin 61 Rhucin 61 histone deacetylase inhibitor 61 refractory prostate cancer 61 Trastuzumab 61 zanolimumab 61 Azacitidine 61 Belimumab 61 REG1 61 Onconase 61 HCV protease 61 inhaled AAT 61 nilotinib 61 ospemifene 61 Pradefovir 61 Alocrest 61 Zelrix 61 GLPG# 61 Cethrin 61 chronic hepatitis C. 61 treatment naive genotype 61 Clonicel 61 glatiramer acetate 61 Locteron 61 Ambrisentan 61 NP2 Enkephalin 61 telaprevir VX 61 HCV protease inhibitors 61 hematological cancers 61 Varespladib 61 MT#/MEDI-# 61 C1 INH 61 REMINYL ® 61 opioid induced bowel dysfunction 61 Factor IX 61 motexafin gadolinium Injection 61 Ramoplanin 61 Ceplene 61 Urocortin 2 61 BrachySil TM 61 SCH # 61 Pirfenidone 61 LUX Lung 61 Raptiva ® 61 Hsp# inhibitor 61 TYGACIL 61 lapatinib Tykerb 61 efalizumab 61 lanthanum carbonate 61 PhosLo 61 Miraxion 61 AZD# 61 Romidepsin 61 Phase Ib clinical 61 nitazoxanide 61 dalbavancin 61 MDV# 61 DAVANAT ® 61 imatinib mesylate Gleevec 61 betrixaban 61 RhuDex ® 61 Canvaxin 61 XL# XL# XL# 61 Anturol TM 61 FavId 61 Randomized Phase 61 GSK# [001] 61 Methylnaltrexone 61 thymalfasin 61 tosedostat 61 ZOLINZA 61 dose cohort 61 fingolimod 61 vernakalant 61 cetuximab Erbitux ® 61 tezampanel NGX# 61 bevacizumab Avastin 61 Telbivudine 61 HSP# inhibitor 61 telaprevir 61 Imprime PGG 61 Xcytrin 61 systemically administered 61 injectable formulation 61 incyclinide 61 GATTEX 61 BRAF V# mutation 61 EGFr 61 Rasagiline 61 Davanat 61 bazedoxifene 61 PSMA ADC 61 sodium thiosulfate STS 61 CB2 selective receptor agonist 61 Puricase 61 relapsed refractory multiple myeloma 61 beta 1a 61 elacytarabine 61 CORLUX 61 TEMODAL 61 octreotide implant 61 Phase III trials 61 humanized monoclonal antibody 61 budesonide foam 61 anti CD3 monoclonal 61 TYKERB 61 FLT3 61 TMC# [001] 61 cabazitaxel 61 ApoB SNALP 61 mTOR inhibitor 61 BYDUREON 61 Revlimid lenalidomide 61 EGFR TKI 61 Phase III clinical trials 61 IMGN# 61 QLT# 61 Golimumab 61 Campath 61 SinuNase 61 HEPLISAV 61 OvaRex R 61 YERVOY 61 BiTE 61 Zoraxel 61 BMS # 61 chronic lymphocytic leukemia CLL 61 BEMA TM Fentanyl 61 SinuNase ™ 61 cangrelor 61 heterozygous FH 61 rhMBL 61 leading oral taxane 61 Erbitux cetuximab 61 clevudine 61 ezogabine 61 Cinryze TM 61 TLK# 61 Syncria 61 polymerase inhibitor 61 muraglitazar 61 GW# [003] 61 IND submission 61 Vimpat R 61 AMD# [003] 61 ketolide antibiotic 61 VitiGam 61 THALOMID 61 R#/MEM 61 Glybera 61 Octreotide 61 cetuximab Erbitux R 61 Phase 2b clinical trials 61 Bendamustine 61 DAPT 61 IgG1 antibody 61 RNAi therapeutic targeting 61 ONCASPAR 61 basiliximab 61 Sorafenib 61 Vidaza 61 SILENOR TM 61 tocilizumab 61 Plenaxis R 61 iclaprim 61 RoACTEMRA 61 Androxal TM 61 BEMA Granisetron 61 AGILECT R 61 RSD# oral 61 ORENCIA R 61 oral Azacitidine 61 interferon therapy 61 JVRS 61 sorafenib Nexavar 61 tamibarotene 61 Vidofludimus 61 OMP #R# 61 APOPTONE 61 MAXY VII 60 anticancer agent 60 exon skipping 60 ACZ# 60 Vimpat ® 60 Thiovir 60 Dacogen 60 FRDA 60 SAR# [002] 60 apricitabine 60 interferon beta 60 IMiDs ® compound 60 metastatic RCC 60 Chrysalin 60 biologic DMARD 60 THR beta agonist 60 severe hypercholesterolemia 60 chimeric monoclonal antibody 60 AEGR 60 JOULFERON 60 PEGylated Fab fragment 60 Phase #/#a trial 60 Microplasmin 60 Reolysin 60 Unit Dose Budesonide 60 Rescula 60 anti leukemic 60 chronic HCV 60 GRN#L 60 temsirolimus 60 tesmilifene 60 filgrastim 60 elagolix 60 thrombopoietin 60 relapsing multiple sclerosis 60 IMiDs 60 BENLYSTA TM 60 SparVax TM 60 rituximab Rituxan ® 60 Phase IIa trial 60 maraviroc 60 ZADAXIN ® 60 HCV infected 60 ISENTRESS 60 CCR5 inhibitor 60 adalimumab 60 MT# MEDI 60 Vernakalant 60 alemtuzumab 60 Phase IIIb clinical 60 ORENCIA ® 60 Myelodysplastic syndromes MDS 60 elinogrel 60 Phase 2a 60 non nucleoside inhibitor 60 tyrosine kinase inhibitor TKI 60 Q#IR 60 Angiox ® 60 antibody MT# 60 BioNumerik 60 Kamada AAT 60 oxymorphone ER 60 Targretin 60 MyVax personalized immunotherapy 60 peptide antigens 60 FIRMAGON R 60 Gamunex 60 immunotherapeutic agent 60 GTC recombinant human 60 lubiprostone